These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23985033)

  • 1. Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine.
    Muscari C; Giordano E; Bonafè F; Govoni M; Pasini A; Guarnieri C
    J Biomed Sci; 2013 Aug; 20(1):63. PubMed ID: 23985033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy.
    Wei ZZ; Zhu YB; Zhang JY; McCrary MR; Wang S; Zhang YB; Yu SP; Wei L
    Chin Med J (Engl); 2017 Oct; 130(19):2361-2374. PubMed ID: 28937044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational insights into stem cell preconditioning: From molecular mechanisms to preclinical applications.
    Moeinabadi-Bidgoli K; Babajani A; Yazdanpanah G; Farhadihosseinabadi B; Jamshidi E; Bahrami S; Niknejad H
    Biomed Pharmacother; 2021 Oct; 142():112026. PubMed ID: 34411911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic preconditioning improves survival of cardiac progenitor cells: role of stromal cell derived factor-1α-CXCR4 axis.
    Yan F; Yao Y; Chen L; Li Y; Sheng Z; Ma G
    PLoS One; 2012; 7(7):e37948. PubMed ID: 22815687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches.
    Das R; Jahr H; van Osch GJ; Farrell E
    Tissue Eng Part B Rev; 2010 Apr; 16(2):159-68. PubMed ID: 19698058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of hypoxia-inducible factor-1alpha in the prevention of cardiomyocyte injury induced by hypoxic preconditioning].
    Xu FF; Liu XH; Cai LR
    Sheng Li Xue Bao; 2004 Oct; 56(5):609-14. PubMed ID: 15497042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy.
    Haque N; Rahman MT; Abu Kasim NH; Alabsi AM
    ScientificWorldJournal; 2013; 2013():632972. PubMed ID: 24068884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise Review: Human Dermis as an Autologous Source of Stem Cells for Tissue Engineering and Regenerative Medicine.
    Vapniarsky N; Arzi B; Hu JC; Nolta JA; Athanasiou KA
    Stem Cells Transl Med; 2015 Oct; 4(10):1187-98. PubMed ID: 26253713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic preconditioning for cell-based therapy and tissue engineering.
    Hsiao ST; Dilley RJ; Dusting GJ; Lim SY
    Pharmacol Ther; 2014 May; 142(2):141-53. PubMed ID: 24321597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of endometrial stem cells in regenerative medicine.
    Massasa EE; Taylor HS
    Regen Med; 2012 Mar; 7(2):133-5. PubMed ID: 22397602
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in cell lineage reprogramming.
    Zhou J; Yue W; Pei X
    Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of hypoxia in stem cell potency and differentiation.
    Hawkins KE; Sharp TV; McKay TR
    Regen Med; 2013 Nov; 8(6):771-82. PubMed ID: 24147532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2.
    Kim HW; Haider HK; Jiang S; Ashraf M
    J Biol Chem; 2009 Nov; 284(48):33161-8. PubMed ID: 19721136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic preconditioning of human mesenchymal stem cells overcomes hypoxia-induced inhibition of osteogenic differentiation.
    Volkmer E; Kallukalam BC; Maertz J; Otto S; Drosse I; Polzer H; Bocker W; Stengele M; Docheva D; Mutschler W; Schieker M
    Tissue Eng Part A; 2010 Jan; 16(1):153-64. PubMed ID: 19642854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced expression of cellular prion protein improves the therapeutic potential of mesenchymal stem cells.
    Han YS; Lee JH; Yoon YM; Yun CW; Noh H; Lee SH
    Cell Death Dis; 2016 Oct; 7(10):e2395. PubMed ID: 27711081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoids: Avatars for Personalized Medicine.
    Clevers HC
    Keio J Med; 2019; 68(4):95. PubMed ID: 31875622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic Preconditioning Induces Neuronal Differentiation of Infrapatellar Fat Pad Stem Cells through Epigenetic Alteration.
    Radhakrishnan S; Martin CA; Dhayanithy G; Reddy MS; Rela M; Kalkura SN; Sellathamby S
    ACS Chem Neurosci; 2021 Feb; 12(4):704-718. PubMed ID: 33508941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell and regenerative medicine.
    Alvarez A; Unda F; Cañavate ML; Hilario E
    Curr Stem Cell Res Ther; 2009 Dec; 4(4):287-97. PubMed ID: 19500064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight on stem cell preconditioning and instructive biomaterials to enhance cell adhesion, retention, and engraftment for tissue repair.
    Shafiq M; Jung Y; Kim SH
    Biomaterials; 2016 Jun; 90():85-115. PubMed ID: 27016619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recents patents for isolating, delivering and tracking adult stem cells in regenerative medicine.
    Fierabracci A
    Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):105-13. PubMed ID: 20156176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.